European Union inspectors from the Netherlands have approved a shipment of medical cannabis products from Uganda’s Industrial Globus Uganda Ltd., the African Exponent reports. The products are a mixture of 2.7 milligrams of THC and 2.5 milligrams of CBD for Sativex drugs, which are produced in the EU, the US, and Canada.
Industrial Globus is a joint venture between Industrial Hemp Uganda and Israel’s Together Pharma. The compliance certificate issued by the EU is valid until August 2020. Benjamin Cadet, Industrial Globus’ director, said the approval affects the company’s entire manufacturing chain. In June, the lack of EU approval prevented the company from exporting products to both Germany and Canada.
In 2017, Industrial Hemp exported $10,000 worth of hemp to South Africa’s National Analysis Forensic Services.
The EU inspectors also certified World Health Organization (WHO) Guidelines on Good Agricultural and Collection Practices for medicinal plants; and the Europe, Middle East, and Africa (EMEA) Guidelines for Good Agricultural and Collection Practices for medicinal plants.
According to the report, at least 50 Ugandan companies have applied for Ministry of Health certification to join Industrial Globus to cultivate medical cannabis.
Last month, officials in Zimbabwe approved plans to allow hemp cultivation for export purposes as it seeks to bolster is foreign currency holdings. Last year, Canada-based Canopy Growth announced it had acquired Kingdom of Lethoso-based Daddy Cann Lethoso PTY Ltd which holds a cannabis export license.
Exclusive offer from our sponsor:
Get daily news insights in your inbox. Subscribe